share_log

【天相投资】金健米业:前三季度扭亏 录得微利

天相投資 ·  Oct 28, 2009 00:00  · Researches

From January to September 2009, the company achieved operating income of 761 million yuan, a year-on-year decrease of 1.6%; operating profit of 7.39 million yuan compared to the same period last year - 8.3 million yuan; net profit attributable to owners of the parent company of 1.14 million yuan compared to -59.55 million yuan in the same period last year; and realized earnings of 0.002 yuan per share. From July to September 2009, the company achieved operating income of 294 million yuan, an increase of 18.9% over the previous year; operating profit - 1.92 million yuan, the same period last year - 60.35 million yuan; net profit attributable to owners of the parent company: 1.71 million yuan, compared to -64.71 million yuan in the same period last year; and realized earnings of 0.003 yuan per share. The reason for the slight year-on-year decline in revenue is: (1) the oil business model has changed from independent management to contract processing, and revenue has declined sharply; (2) there are no new development projects in the real estate business. The reasons for the year-on-year decline in net profit are: (1) asset impairment losses fell sharply year on year in January-September, asset impairment losses were 6.9 million yuan, compared with 62.52 million yuan in the same period last year; (2) gross margin increased 1.6 percentage points to 18%. The rapid growth of the pharmaceutical industry is an important point of view for future performance. With the smooth commissioning of the third phase of the pharmaceutical industry project, the company sold 78.23 million bottles (bags) of large infusions in the first half of the year, an increase of 82.2% over the previous year. We believe that the pharmaceutical industry will be an important focus of the company's future profit growth. The company's EPS for 2009-2010 is expected to be 0.01 yuan and 0.03 yuan. Based on the closing price of 6.6 yuan on October 27, the corresponding dynamic price-earnings ratios are 660X and 220X, respectively, maintaining a “neutral” rating. Risk warning: (1) the natural risks of rice cultivation (2) the risks posed by poor management.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment